Selected Publications from 2023

Publications

What do women think about having received their breast cancer risk as part of a risk stratified NHS Breast Screening Programme? A qualitative study.
L McWilliams, H Ruane, F Ulph, VG Woof, F Harrison, DG Evans, & DP French
British Journal of Cancer   2023  129; 356-365.   P228. DOI: 10.1038/s41416-023-02268-0
 
RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells
Chen F, Gurler S, Novo D, Selli C, Alferez D, Eroglu S, Pavlou K, Zhang J, Sims A, Humphreys N, Adamson A, Campbell A, Sansom O, Tournier C, Clarke R, Brennan K, Streuli C, Ucar A
Oncogene  2023  42   pages679–692 DOI: 10.1038/s41388-022-02574-6
 
Psychological impact of risk stratified screening as part of the NHS Breast Screening Programme: Multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
DP French, L McWilliams, S Bowers, V Woof, F Harrison, H Ruane, A Hendy & DG Evans (2023).
British Journal of Cancer   2023  128; 1548-1558.  P214
 
Efficient Management of New Patient Referrals to a Breast Service: The Safe Introduction of an Advanced Nurse practitioner (ANP) Led Telephone Breast Pain Service
Ellis KS, Robinson CE, Foster R, Fatayer H, Gandhi A
Ann Royal Coll Surg published online 29 August 2023  2023  doi.org/10.1308/rcsann.2023.0056 
 
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Evans DG, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS, Harkness EF, Harrison F, Harvie M, Jerrison A, Machin M, Maxwell AJ, Howell SJ, Wright SJ, Payne K, Qureshi N, Ruane H, Southworth J, Fox L, Bowers S, Hutchinson G, Thorpe E, Ulph F, Woof V, Howell A, French DP.
Br J Cancer  2023  Apr 1:1-9. doi: 10.1038/s41416-023-02250-  
 
Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
French DP, McWilliams L, Bowers S, Woof VG, Harrison F, Ruane H, Hendy A, Evans DG
Br J Cancer  2023  Feb 11. doi: 10.1038/s41416-023-02156-7 
 
Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic
Harvie M, French DP, Pegington M, Lombardelli C, Krizak S, Sellers K, Barrett E, Gareth Evans D, Cutress R, Wilding Rgn A, Graves L, Howell A
Br J Cancer  2023  May;128(9):1690-1700.   doi: 10.1038/s41416-023-02207-z.
 
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group
N Engl J Med  2023  Jun 1;388(22):2058-2070  doi: 10.1056/NEJMoa2214131
 
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy
Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke RB, Belfiore A and De Francesco EM
Endocrine Reviews  2023  Mar 4; doi: 10.1210/endrev/bnad005 
 


Seminars

Date:  15 February 2024, 00:00
Speaker:  Jason Carroll
From:  University of Cambridge
Title:  TBC
Host:  Sankari Nagarajan